Universitaire Ziekenhuizen Leuven
Leuven, 3000, Belgium
NCT Number: NCT01879124
The purpose of this study is to evaluate the prognostic performance of intrarenal resistive index in the first years after kidney transplantation on graft function and on patient and graft survival. In addition, the determinants of the intrarenal resistive index, including a detailed analysis of the relation between graft histology and the intrarenal resistive index, will be assessed.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Leuven, 3000, Belgium
Since March 2004, and as part of routine clinical practice, protocol renal allograft biopsies are routinely performed at implantation and at 3, 12 and 24 months after transplantation, in all patients who receive a kidney transplant at the University Hospitals Leuven, unless there is a medical contra-indication or patient refusal to undergo this procedure. The biopsies are scheduled using a dedicated Microsoft Access database ("Biopsy Database"), that is maintained on the central servers of the University Hospitals Leuven. Patients who have an unexplained change in renal allograft function, undergo additional clinically indicated indication biopsies. These biopsies are also recorded in the aforementioned Microsoft Access Database.
All clinical data, including pretransplant donor and recipient characteristics, and post-transplant follow-up data are directly stored and maintained in a prospectively collected electronic database (CCL database until 06/2012, transferred to the central KWS database in 2012). This electronic database is the only existing clinical database for these patients, and contains all clinical patient charts. No written records are collected.
All renal allograft biopsies will be rescored by a single renal pathologist according to the most recent Banff classification, blinded for the clinical parameters and timing of the biopsy. These rescoring data are directly entered in the dedicated Microsoft Access database ("Biopsy Database").
Just prior to performing a renal allograft biopsy with ultrasound guidance, and as part of the routine clinical procedure, duplex measurements are performed by the radiologist who will perform the biopsy. The peak systolic velocity (Vmax) and the minimal diastolic velocity (Vmin) are determined in each patient in two to three representative interlobar arteries. The resistive index is calculated as [1 - (V min/V max)]. This procedure is repeated at three different places in the kidney (lower, interpolar and upper pole). These data are directly entered in the central electronic clinical database system (KWS, see above).
All electronic data will be transferred to a SAS database at time of data extraction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Single kidney transplantation
Exclusion criteria
None
Time frame: 7 years after transplantation
Time frame: 7 years after transplantation
Time frame: 7 years after transplantation
Time frame: 7 years after transplantation
Universitaire Ziekenhuizen KU Leuven
Other
Correlation Between Renal Vascular Resistive Index, Renal Allograft Histology and Outcome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03418181
Dialysis, Female Urogenital Diseases
Stevenage, United Kingdom
View Trial DetailsNCT07704008
Anxiety Disorders, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT01595984
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amiens, France
View Trial DetailsNCT00213590
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Rouen, France
View Trial Details